Cyclosporin in childhood psoriasis
- PMID: 12775319
Cyclosporin in childhood psoriasis
Abstract
Cyclosporin is known to be highly effective in the treatment of psoriasis in adults. It has also proved effective and well tolerated in the treatment of severe childhood atopic dermatitis. Psoriasis in childhood is relatively unusual but by no means rare and on occasions the disease can be very difficult to control in this age group. The use of cyclosporin for psoriasis in childhood has received scarcely any attention and in the few cases that have been reported the results have been inconsistent. Three children aged from 7 to 11 years with severe psoriasis resistant to topical agents were treated with cyclosporin. The highest dose required was 3.5 mg/kg per day. The duration of treatment ranged from 6 weeks to 4 months. Cyclosporin was effective and generally well tolerated. Treatment was interrupted in one case due to nausea and diarrhoea. None of the patients developed hypertension or renal impairment. The potential role of cyclosporin in severe childhood psoriasis is discussed.
Similar articles
-
Cyclosporin A treatment in severe childhood psoriasis.J Eur Acad Dermatol Venereol. 2006 Jul;20(6):651-6. doi: 10.1111/j.1468-3083.2006.01562.x. J Eur Acad Dermatol Venereol. 2006. PMID: 16836490 Review.
-
Clinical experience with the use of cyclosporin A in psoriasis. Results of a retrospective study.J Dermatolog Treat. 2005;16(4):238-41. doi: 10.1080/09546630510011829. J Dermatolog Treat. 2005. PMID: 16249146
-
The correlation between response to oral cyclosporin therapy and systemic inflammation, metabolic abnormality in patients with psoriasis.Arch Dermatol Res. 2008 Nov;300(10):545-50. doi: 10.1007/s00403-008-0887-5. Epub 2008 Sep 17. Arch Dermatol Res. 2008. PMID: 18797895 Clinical Trial.
-
Severe atopic dermatitis treated with everolimus.J Dermatolog Treat. 2009;20(6):365-7. doi: 10.3109/09546630903085294. J Dermatolog Treat. 2009. PMID: 19954394
-
Treatment of psoriasis. Part 2. Systemic therapies.J Am Acad Dermatol. 2001 Nov;45(5):649-61; quiz 662-4. doi: 10.1067/mjd.2001.117047. J Am Acad Dermatol. 2001. PMID: 11606913 Review.
Cited by
-
Treating pediatric plaque psoriasis: challenges and solutions.Pediatric Health Med Ther. 2016 Apr 21;7:25-38. doi: 10.2147/PHMT.S75834. eCollection 2016. Pediatric Health Med Ther. 2016. PMID: 29388608 Free PMC article. Review.
-
Role of Cyclosporine (CsA) in Immuno-dermatological Conditions.Indian Dermatol Online J. 2022 Sep 5;13(5):585-599. doi: 10.4103/idoj.idoj_189_22. eCollection 2022 Sep-Oct. Indian Dermatol Online J. 2022. PMID: 36304637 Free PMC article.
-
Systemic Treatment of Pediatric Psoriasis: A Review.Dermatol Ther (Heidelb). 2016 Jun;6(2):125-42. doi: 10.1007/s13555-016-0117-6. Epub 2016 Apr 16. Dermatol Ther (Heidelb). 2016. PMID: 27085539 Free PMC article. Review.
-
Management of psoriasis in adolescence.Adolesc Health Med Ther. 2014 Mar 14;5:25-34. doi: 10.2147/AHMT.S36672. eCollection 2014. Adolesc Health Med Ther. 2014. PMID: 24729738 Free PMC article. Review.
-
Off-Label Treatments for Pediatric Psoriasis: Lessons for the Clinic.Psoriasis (Auckl). 2021 Feb 11;11:1-20. doi: 10.2147/PTT.S268462. eCollection 2021. Psoriasis (Auckl). 2021. PMID: 33604269 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical